Stage 4 Metastatic Breast Cancer Treatment- Marcella's Envita Review
Her strong determination to defy poor prognosis for her stage 4 breast cancer compelled Marcella to look for advanced targeted integrative options, going beyond standard oncology care. “My goal is to live, I plan to walk out cancer free!” said Marcella Wiliams, who traveled from Arkansas to Envita Medical Centers, a Center of Excellence for Precision Integrative Oncology, located in Scottsdale, Arizona. She refused to accept the two years of life given to her by standard oncology, because she believed there were more options for her.
Disclaimer: Individual results will vary. Envita makes no guarantees for outcomes. Each patient case is unique. Please consult your doctor before making any changes to your medical treatment. Not every patient is a candidate for care or achieves these results. Treatments used in this case may not all be FDA approved for the treatment of this condition.
Late-Stage Diagnosis Despite Regular Checks
Marcella had noticed several breast lumps 25 years ago, but biopsies at that time had not indicated any concerns of cancer. However, since then she had been regular about her annual mammograms and other screenings, which did not catch anything, till Marcella noticed a big lump. Mammograms and biopsies then confirmed that Marcella had breast cancer with metastatic spread to her liver and bones.
Due to this late-stage diagnosis, Marcella's prognosis did not seem optimistic. However, at Envita, our team of specially trained physicians utilize the advanced precision integrative oncology approach, combining the latest conventional medicine with research-based natural therapies. This innovative approach is designed to not only target the cancerous cells but also strike at the core cause of the disease, while bolstering the patient's immune system for lasting outcomes. “That was the value to us for choosing this place,” said Ken, Marcella's husband, a cancer survivor himself.
Personalized Proprietary Treatments and Immunotherapies
Envita's personalized precision approach is based on detailed genomic analysis as well as other specialty tests, which are aimed at identifying the unique set of causative factors responsible for triggering disease in each individual patient. This detailed knowledge about each patient's cancer helps to custom-develop treatment protocols for each individual patient, like Marcella, increasing their chances of achieving lasting outcomes, going beyond the standard one-size-fits-all approach.
Marcella benefitted greatly from our proprietary treatments like GTFC™ (Genetically Targeted Fractionated Chemotherapy), which is designed to enhance the mechanisms of action against cancer, while reducing the chances of side effects. “I can't complain about the chemo, I can do it again,” said Marcella.
GTFC™ is based on tests which help to identify the most appropriate chemotherapy agents for each individual patient, as a result it utilizes a greater number of chemotherapy agents than standard maximum therapeutic dose untargeted chemotherapy. However, their low dosage and the targeted precision delivery mechanism, makes them more impactful on the cancerous cells, without affecting the surrounding healthy cells. Minimal impact to the healthy cells, along with other supportive targeted immunotherapies, play a crucial role in helping patients progress towards a holistic recovery.
Found Comfort in Envita's Receptive Doctors
“My goal was that whatever doctor I have, has the same hope, and they're going to fight as hard as we're going to fight. And we knew immediately, at the end of that meeting, that's what we had,” said Marcella, referring to her first consultation at Envita. The couple felt grateful for not only receiving precision targeted integrative oncology treatment but receiving it in an ecosystem where they felt loved and valued. “We don't want to be a number; we want to be part of a family and Envita seems to treat everybody like a family member,” added Ken, who stayed with Marcella during her treatment at Envita.
Her Envita Connection
Marcella was inclined towards pursuing integrative care, after reading a book about it, however she zeroed in on Envita based on the first-hand account of one of our former patients. This residential builder was encouraged to seek care at Envita after she heard about the successful recovery of a client's son at Envita. Though he was treated for Lyme disease, his outstanding outcome motivated Marcella to deviate from her course of standard oncology care. She feels fortunate about taking that decision, as after her treatment at Envita, she was able to implement her plan of walking out cancer free with no evidence of disease in her body.
Call Us Today
Envita's specially trained team includes oncologists, interventional radiologists, researchers, and pharmacists, who undergo over 1,500 hours of intensive training in the unique approach of personalized precision integrative oncology. They collaborate to create tailored treatment strategies for potentially improving the patient's quality of life, increasing longevity, and reducing toxicities. For any inquiries regarding cancer, feel free to reach out to us at 866-830-4576.
